These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1338350)

  • 21. Intravenous immunoglobulins as therapeutic agents.
    Stiehm ER; Ashida E; Kim KS; Winston DJ; Haas A; Gale RP
    Ann Intern Med; 1987 Sep; 107(3):367-82. PubMed ID: 3304051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH; Duffy CE; Shulman ST
    J Pediatr; 1988 Aug; 113(2):290-4. PubMed ID: 2456378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
    Winston DJ; Gale RP
    Bone Marrow Transplant; 1991 Jul; 8(1):7-11. PubMed ID: 1655140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kawasaki disease. Some recent studies on pathogenetic mechanisms.
    Tay JS
    J Singapore Paediatr Soc; 1990; 32(1-2):11-3. PubMed ID: 1701839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J; Peppard J; Emanuel D
    Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease.
    Adler SP; Nigro G
    Herpes; 2008 Nov; 15(2):24-7. PubMed ID: 19856544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reality and clinical application of immunoglobulin preparations].
    Miyara T; Saito A
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):824-8. PubMed ID: 8753046
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
    Gratwohl A; Doran JE; Bachmann P; Scherz R; Späth P; Baumgartner C; Perret B; Berger C; Nissen C; Tichelli A
    Bone Marrow Transplant; 1991 Oct; 8(4):275-82. PubMed ID: 1661632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
    Chaker L; Drissa MA; Drissa H
    Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis.
    Meissner HC; Schlievert PM; Leung DY
    Immunol Rev; 1994 Jun; 139():109-23. PubMed ID: 7927408
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoglobulin preparations].
    Ono Y
    Nihon Rinsho; 2012 Apr; 70(4):629-34. PubMed ID: 22568145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic uses of intravenous gammaglobulin for pediatric infections.
    Fischer GW
    Pediatr Clin North Am; 1988 Jun; 35(3):517-33. PubMed ID: 3131724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Kawasaki syndrome with intravenous gamma globulin.
    Murphy DJ; Huhta JC
    N Engl J Med; 1987 Apr; 316(14):881. PubMed ID: 2434852
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences in immunoglobulin preparations and outcome of Kawasaki disease.
    Yavuz H; Ozel A
    J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453
    [No Abstract]   [Full Text] [Related]  

  • 38. NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease.
    JAMA; 1990 Dec; 264(24):3189-93. PubMed ID: 2255028
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravenous immunoglobulin substitution in patients with ARC and AIDS (WR 3-6)].
    Kiehl M; Stoll R; Domschke W
    Immun Infekt; 1994 Apr; 22(2):53-5. PubMed ID: 7959860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive immunization.
    Raab CP
    Prim Care; 2011 Dec; 38(4):681-91, viii. PubMed ID: 22094139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.